Cambridge technology firm Lab21 has acquired Biotec Laboratories, an Ipswich-based clinical diagnostic company. The terms of the deal remain undisclosed. 

Cambridge technology firm Lab21 has acquired Biotec Laboratories, an Ipswich-based clinical diagnostic company. The terms of the deal remain undisclosed.

As part of the sale, Lab21 has also acquires Biotec’s South African subsidiary, Biotec Laboratories SA, which is a joint venture with the Cape Biotech Trust. The deal is in line with Lab21’s strategy to enter new markets and expand its global reach.

Lab21 CEO Graham Mullis said: “Our goal is to grow Lab21 into a major international diagnostics business through both organic growth and acquisition – this transaction is an important step in that process. Our combined businesses, which have very complementary products, provide a great platform from which to build further our infectious disease and immunodiagnostic portfolio.”